Owner Novartis AG

Inventors Leppert, David; Wallstroem, Erik; Nuesslein-Hildesheim, Barbara

Agent Davies Collison Cave

Pub. Number AU-A-2009284224

PCT Pub. Number WO2010/020609

Priority 08162522.0 18.08.08 EP

Filing date 17 August 2009

Wipo publication date 25 February 2010

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/417 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/436 (2006.01)

A61K 31/52 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/00 (2006.01) Drugs for disorders of the nervous system